One of 55 patients transplanted for sclerosing cholangitis during the cyclosporin-steroid era (March 1980-June 1986 developed intrahepatic biliary strictures in the absence of allograft rejection within the 1st year posttransplantation. Although many causes underlie biliary pathology in the postoperative period (i.e., arterial injury, ischemia, chronic rejection, cholangitis), recurrent disease remains a possibility.
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Biliary tract complications after orthotopic liver transplantation (OLT) are frequent; they are mostly due to inappropriate reconstruction of the extrahepatic bile duct [11. Recurrent disease in the allograft is common after OLT in malignant biliary tract disease but is very rare in benign biliary tract disease [2] [3] [4] [5] [6] . A patient presenting with a possible recurrent sclerosing cholangitis some months after liver transplantation is discussed.
Case report
On August 21, 1984, a 34 year-old male underwent OLT with a graft of identical blood group, type A, for end-stage primary sclerosing cholangitis (PSC) (Fig.l) . He had been under medical management for severe ulcerative colitis since the age of 21. His past medical history revealed an uncomplicated cholecystectomy at age 27 and an appendectomy for perforative appendicitis 1982 and 1983 . Finally, a choledochojejunostomy was carried out using a transhepatic, transanastomotic U-tube, which was removed 4 months later. Repeated evaluations showed a progressive worsening of the liver disease, justifying a recommendation for treatment by OLT. The cholestasis worsened (total bilirubin, 23 mg%; alkaline phosphatases, 2020 IU). Osteoporosis was responsible for compression fractures of thoracic vertebrae 8-10 and an aseptic necrosis of the left femoral head. Gastrointestinal bleeding due to portal hypertension also occurred.
The liver grafting was uneventful: the allograft had a single arterial supply, the liver was reperfused after the completion of all four vascular anastomoses, and cold and warm ischemic times were within normal limits. The former Roux-en-Y-jejunal loop was reused for the end-to-side choledochojejunostomy. The anastomosis was carried out using a 12 French-feeding-tube stent and interrupted, absorbable 5-0 vicryl sutures. An intraoperative cholangiogram showed a normal intra-and extrahepatic biliary tree, an absence of leakage, and a patent anastomosis. The postoperative course was uneventful and the patient was discharged 20 days postsurgery with nearly normal liver function tests (LFT) [total/conjugated bilirubin (bil.t/conj), 1.7/0.9mg%; alkaline phosphatase (alk.phos.) 228 IU; transaminases (SGPT/SGOT), 150/25 IU/1; Gamma-glutamyl-transpeptidase (G GTP), 64 IU; protime (PT), 11 s]. The rapid postoperative normalization of transaminases precluded major ischemic injury to the altograft during procurement and reimplantation.
On January 11, 1985, the patient was readrnitted due to abnormal LFT (bil.t., 1.4 rag%; alk.phos., 725 IU; SGPT/SGOT, 400/268IU/1; GGTP, 204IU; PT, t2s). The patient had no cholestatic symptoms. The biochemical abnormalities were attributed to an impaired cyclosporin absorption due to large amounts of diarrhea associated with a flu. Adjustment of the cyclosporin dose almost immediately normalized liver function (bil.t/conj, 0.5/0.1 rag%; alk.phos., 341 IU; G GTP, 257IU; SGPT/SGOT, 51/28 IU/1). A liver biopsy showed early changes of bile duct obstruction, such as duct dilatation, portal edema, marginal duct proliferation, and ductal ec~asia. There were no remarkable signs of rejection, viral infection, or drug toxicity.
On February 20, 1985, the patient was rehospitalized due to persistent liver function abnormalities in the absence of clinical symptoms (bil.t/conj., 1.8/0.2mg%; alk. phos., 587 IU; SGPT/SGOT, 462/321 IU/I; G GTP, 365 IU; PT, 11.4 s). A liver firmed peripheral intrahepatic bilia~' strictures in the presence of a patent choledochojejunostomy. The liver function abnormalities persisted on different occasions between May t985 and June t987 (bil.t., 0.5rag%; alk.phos., 910IU; SGPT/SGOT, 145/82 IU/1; PT, tl.7 s). Histological examinations showed progression of the biliary obstruction and advancing portal fibrosis without evidence of graft rejection (Fig.3) . On one occasion, a lymphogranulomatoid nodule was seen near an interlobular bile duct (Fig.4) . Portal inflammation was otherwise minimal. More than 3.5 years posttransplantation, the graft is still functioning well, whida precludes a further histological examination of the organ as well as modification of the low-dose steroid-cyctosporin therapy.
